Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first ...
Miplyffa is the first drug approved for treating associated neurological symptoms in adults and children 2 years and older. HealthDay News — The U.S. Food and Drug Administration has approved Miplyffa ...
WellSpan Health has been approved for a nearly $1 million funding award by the Patient-Centered Outcomes Research Institute ...